Seventy-four women newly diagnosed with breast cancer completed baseline assessment measures within the two weeks prior to their first chemotherapy treatment or hormonal therapy. The majority of women were Caucasian (91%), ranged in age from 25 to 89 $(M=45),$ and were diagnosed with Stage I or II breast cancer.
Seventy-four women newly diagnosed with breast cancer completed baseline assessment measures within the two weeks prior to their first chemotherapy treatment or hormonal therapy. The majority of women were Caucasian (91%), ranged in age from 25 to 89 $(M=45),$ and were diagnosed with Stage I or II breast cancer.